Anixa Biosciences, Inc. announced the appointment of Thomas Schlumpberger, Ph.D., as Executive Vice President, Diagnostics. Dr. Schlumpberger will be responsible for the development and commercialization of Cchek™, Anixa's artificial intelligence driven liquid biopsy for early cancer detection. Dr. Schlumpberger is an experienced executive with more than 20 years of experience working in the life sciences industry. Prior to joining Anixa, Thomas held senior executive roles with several diagnostic companies, including InVitae, Affymetrix (now Thermo-Fisher Scientific), Inivata and Singulex.